News

DEA Targets New Drug, Kratom, Schedule 1 Substance like Heroin
Posted by UTS -

The U.S. Drug Enforcement Agency (DEA) has added another drug to its controlled-substance list. This drug, which is growing acclaim for its various uses, is also still relatively unknown to most of the general public. Kratom, or Ketum, is a plant species Mitragyna speciosa which is most related to the coffee plant. Kratom has been promoted on many websites as a “safe and harm free” herbal supplement to treat aches and pain.   What does the DEA think?   Well, on September 30, 2016, the DEA will include kratom on its Schedule 1 Controlled Substance List. This classification will put kratom...

View Article →

New Study Shows, More Babies Born Drug Dependent - One Every Hour
Posted by UTS -

  Since 2009, over 13 thousand babies were born with drug withdrawal symptoms and this number continues to grow each year, putting it at a rate of one baby per hour.  "We were surprised by the magnitude of the increase," says researcher Stephen Patrick, MD, MPH, a Robert Wood Johnson clinical scholar at the University of Michigan.   So, what is drug dependence? And are babies growing more addicted to drugs? Drug dependence occurs when a person develops a physical dependence on a drug, disabling them from leading a normal and healthy lifestyle. This dependence leads to withdrawal symptoms if...

View Article →

Opioid Addiction Crisis: Harvard Medical Students Request Better Training
Posted by UTS -

img source: Michael Dykstra   Back in March, The White House asked medical schools to sign a pledge to require students to learn new federal guidelines for safe opioid prescription use. “We are over 10 years into this epidemic, and I don’t think we’ve seen a robust enough response from the medical community,” said Michael Botticelli, head of the White House Office of National Drug Control Policy. Dr. Ted Parran of Case Western Reserve School of Medicine has taught remedial courses for doctors who tend to over-prescribe painkillers. He’s taught this for over 20 years!   Last November, Governor Charlie...

View Article →

Neos Therapeutics: Dissolvable Amphetamine Drug for Kids
Posted by UTS -

img source: neos therapeutics   Recently, the CDC has raised concerns with over-medicating children with ADHD.   Enter Adzenys – a new medication in this ADHD market. This new dissolvable pill aimed directly at children for its ease-of-use and orange-flavoring is concerning doctors and parents due to the fact that the medication is a Schedule 2 Controlled Substance, and the drug’s main selling point of “ease-of-use” may facilitate abuse. With such a widespread use of stimulants being used in today’s society, many in the medical community insist that creating an ODT (orally disintegrating tablet) version of an ADHD drug is a...

View Article →

Eli Lilly Pharma Giant Reveals Plans to Release 20 New Drugs in 5 Years
Posted by UTS -

      Indianapolis-based pharmaceutical giant Eli Lilly lly laid out an ambitious R&D agenda for launching up to 20 new drugs by 2023 during an investor presentation in May. Eli said it hopes to add a significant number of uses for its existing therapies in order to bolster those drugs’ market strength. They will focus on key franchises such as diabetes, oncology, and neurodegenerative diseases, such as Alzheimer’s. In addition, they will add immunology to their core therapeutic spaces. The pharma giant also had to ditch one of its pipeline hopefuls, a cardiovascular treatment meant to boost -good- HDL cholesterol,...

View Article →